[{"_id":"551f89b731cae9239deb1f1f","会社名":"(株)医学生物学研究所【4557】","証券コード":"4557","決算期":"2014年3月期","会計方式":"日本方式","決算発表日":"2014年5月2日","決算月数":"12か月","売上高":"7,172百万円","営業利益":"-519百万円","経常利益":"-476百万円","当期利益":"-418百万円","EPS（一株当たり利益）":"-16.20円","調整一株当たり利益":"---","BPS（一株当たり純資産）":"337.03円","総資産":"13,021百万円","自己資本":"8,714百万円","資本金":"4,482百万円","有利子負債":"2,992百万円","自己資本比率":"66.9%","ROA（総資産利益率）":"-3.16%","ROE（自己資本利益率）":"-4.68%","総資産経常利益率":"-3.60%","__v":0,"日付":"2015-04-04T06:50:31.283Z"},{"_id":"551f89b731cae9239deb1f20","会社名":"(株)医学生物学研究所【4557】","証券コード":"4557","決算期":"2013年3月期","会計方式":"日本方式","決算発表日":"2013年5月13日","決算月数":"12か月","売上高":"6,924百万円","営業利益":"238百万円","経常利益":"319百万円","当期利益":"213百万円","EPS（一株当たり利益）":"12.39円","調整一株当たり利益":"---","BPS（一株当たり純資産）":"354.47円","総資産":"13,402百万円","自己資本":"9,165百万円","資本金":"4,482百万円","有利子負債":"3,035百万円","自己資本比率":"68.4%","ROA（総資産利益率）":"1.95%","ROE（自己資本利益率）":"3.11%","総資産経常利益率":"2.93%","__v":0,"日付":"2015-04-04T06:50:31.284Z"},{"_id":"551f89b731cae9239deb1f21","会社名":"(株)医学生物学研究所【4557】","証券コード":"4557","決算期":"2012年3月期","会計方式":"日本方式","決算発表日":"2012年5月11日","決算月数":"12か月","売上高":"6,562百万円","営業利益":"381百万円","経常利益":"309百万円","当期利益":"318百万円","EPS（一株当たり利益）":"18.59円","調整一株当たり利益":"---","BPS（一株当たり純資産）":"264.08円","総資産":"8,405百万円","自己資本":"4,529百万円","資本金":"2,228百万円","有利子負債":"2,838百万円","自己資本比率":"53.9%","ROA（総資産利益率）":"3.88%","ROE（自己資本利益率）":"7.31%","総資産経常利益率":"3.77%","__v":0,"日付":"2015-04-04T06:50:31.284Z"}]